Researcher looking at flask in lab

AstraZeneca to fund a further 55 PhD studentships with University of Cambridge

12 July 2022

The University of Cambridge has formed a new agreement with AstraZeneca for the global biopharmaceuticals company to fund 55 additional PhD studentships over the next five years, starting in October 2022. Over the last 20 years, AstraZeneca has funded more than 100 PhD students from the University as part of a longstanding partnership between the two institutions.

Read More
Neurons

Heal thyself

24 May 2021

Three companies, Astex Pharmaceuticals, Eisai Ltd and Eli Lilly and Company, are joining forces with research scientists across Cambridge to explore promising new approaches to the treatment of neurodegenerative disease.

Read More